canadian pharmacy semaglutide Health Canada warns about fake or unauthorized versions of GLP-1 drugs Canadian pharmacy platform to offer

Spoken like a true hit piece

2 Although the pancreatic effects of GLP-1 (glucose-dependent insulin secretion and glucagon suppression) are well-established, its extrapancreatic actions are increasingly being recognised as critical to the therapeutic effects of GLP-1RAs

Potential for Hypoglycemia: Although less common when used alone, semaglutide can cause hypoglycemia (low blood sugar) when used with other glucose-lowering medications, such as insulin or sulfonylureas

These figures come from the trial manuscripts and FDA labeling and are not guarantees for any individual, which is why a provider frames realistic expectations